Advisory Services Network’s Vanda Pharmaceuticals VNDA Stock Holding History

Advisory Services Network’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21	Closed	-$145	–	4547
2026 Q1	$145	Buy	+21	New	+$162	﹤0.01%	4623
2025 Q4	–	Sell	-21	Closed	-$105	–	4171
2025 Q3	$105	Buy	+21	New	+$97	﹤0.01%	4348
2020 Q4	–	Sell	-150	Closed	-$1.81K	–	3732
2020 Q3	$1K	Buy	+150	New	+$1.6K	﹤0.01%	3423
2017 Q2	–	Sell	-500	Closed	-$7K	–	2382
2017 Q1	$7K	Buy	+500	New	+$7.13K	﹤0.01%	1613
2016 Q3	$15K	Sell	900 -500	-36%	-$6.73K	﹤0.01%	1198
2016 Q2	$16K	Sell	1,400 -2,650	-65%	-$25.7K	﹤0.01%	1075
2016 Q1	$34K	Sell	4,050 -1,300	-24%	-$10.7K	0.01%	767
2015 Q4	$50K	Hold	5,350	–	–	0.02%	585
2015 Q3	$60K	Buy	5,350 +500	+10%	+$6.12K	0.02%	499
2015 Q2	$61K	Buy	+4,850	New	+$52.3K	0.02%	470

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisory Services Network's VNDA Position: Q2 2026 in Review

Advisory Services Network sold out of Vanda Pharmaceuticals (VNDA) in Q2 2026, closing a stake of 21 shares — an estimated $145 sold.

Advisory Services Network first reported a position in VNDA in Q2 2015 and held it in 10 quarters. The position peaked at $61K in Q2 2015. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

Advisory Services Network reported no remaining Vanda Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 21 Vanda Pharmaceuticals shares in Q2 2026, an estimated $145.
Advisory Services Network first reported a position in Vanda Pharmaceuticals in Q2 2015 and held it in 10 quarters.
Advisory Services Network's Vanda Pharmaceuticals position peaked at $61K in Q2 2015.
172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.